These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6699660)
1. Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma. Trent JM; Buick RN; Olson S; Horns RC; Schimke RT J Clin Oncol; 1984 Jan; 2(1):8-15. PubMed ID: 6699660 [TBL] [Abstract][Full Text] [Related]
2. A comparison of the propensity for gene amplification between near-tetraploid and near-diploid V79 clones resistant to 150 nM methotrexate. Hashimoto MW; Nikaido O; Kobayashi N; Chang CC; Trosko JE; Mori T Carcinogenesis; 1996 Mar; 17(3):389-94. PubMed ID: 8631121 [TBL] [Abstract][Full Text] [Related]
3. Gene amplification in a leukemic patient treated with methotrexate. Horns RC; Dower WJ; Schimke RT J Clin Oncol; 1984 Jan; 2(1):2-7. PubMed ID: 6583327 [TBL] [Abstract][Full Text] [Related]
4. Resistance to methotrexate due to gene amplification in a patient with acute leukemia. Carman MD; Schornagel JH; Rivest RS; Srimatkandada S; Portlock CS; Duffy T; Bertino JR J Clin Oncol; 1984 Jan; 2(1):16-20. PubMed ID: 6583326 [TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells]. Sakai K Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466 [TBL] [Abstract][Full Text] [Related]
6. Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells. Morales C; García MJ; Ribas M; Miró R; Muñoz M; Caldas C; Peinado MA Mol Cancer Ther; 2009 Feb; 8(2):424-32. PubMed ID: 19190117 [TBL] [Abstract][Full Text] [Related]
7. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase. Bürkle A; Heilbronn R; zur Hausen H Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of resistance to antifolates, a review. Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336 [TBL] [Abstract][Full Text] [Related]
9. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate]. Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154 [TBL] [Abstract][Full Text] [Related]
10. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate. Vinh DB; McIvor RS J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174 [TBL] [Abstract][Full Text] [Related]
11. Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro. Banerjee D; Zhao SC; Tong Y; Steinherz J; Gritsman K; Bertino JR Cancer Gene Ther; 1994 Sep; 1(3):181-4. PubMed ID: 7621249 [TBL] [Abstract][Full Text] [Related]
12. Increase of dihydrofolate reductase in peripheral blood lymphocytes of rheumatoid arthritis patients treated with low-dose oral methotrexate. Rodenhuis S; Kremer JM; Bertino JR Arthritis Rheum; 1987 Apr; 30(4):369-74. PubMed ID: 3580007 [TBL] [Abstract][Full Text] [Related]
13. A new myeloblastic leukemia cell line with double minute chromosomes. Induction of methotrexate resistance and dihydrofolate reductase gene amplification. Saito H; Kishi K; Narita M; Furukawa T; Nagura E; Maekawa T; Abe T; Shibata A Leuk Res; 1992; 16(3):217-26. PubMed ID: 1560671 [TBL] [Abstract][Full Text] [Related]
14. [Methotrexate and its drug resistance]. Nagura E Gan To Kagaku Ryoho; 1988 Oct; 15(10):2882-7. PubMed ID: 3178237 [TBL] [Abstract][Full Text] [Related]
15. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Göker E; Waltham M; Kheradpour A; Trippett T; Mazumdar M; Elisseyeff Y; Schnieders B; Steinherz P; Tan C; Berman E Blood; 1995 Jul; 86(2):677-84. PubMed ID: 7605998 [TBL] [Abstract][Full Text] [Related]
16. DHFR gene amplification in cultured skin fibroblasts of ataxia telangiectasia patients after methotrexate selection. Lücke-Huhle C; Hinrichs S; Speit G Carcinogenesis; 1987 Dec; 8(12):1801-6. PubMed ID: 2824082 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc. Denis N; Kitzis A; Kruh J; Dautry F; Corcos D Oncogene; 1991 Aug; 6(8):1453-7. PubMed ID: 1886715 [TBL] [Abstract][Full Text] [Related]
18. Mitogenic hormones and tumor promoters greatly increase the incidence of colony-forming cells bearing amplified dihydrofolate reductase genes. Barsoum J; Varshavsky A Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5330-4. PubMed ID: 6351057 [TBL] [Abstract][Full Text] [Related]
19. Transgenic mice expressing the tyr22 variant of murine DHFR: protection of transgenic marrow transplant recipients from lethal doses of methotrexate. James RI; May C; Vagt MD; Studebaker R; McIvor RS Exp Hematol; 1997 Nov; 25(12):1286-95. PubMed ID: 9357973 [TBL] [Abstract][Full Text] [Related]